Prognostic Analysis of Completely Resected Lung Adenocarcinoma with Uncommon EGFR Mutations: CReGYT-01 EGFR Study

被引：0

作者：

Hayasaka, K. ^{[1
,2
]}

Haratake, N. ^{[3
]}

Notsuda, H. ^{[2
]}

Katsumata, S. ^{[1
]}

Hamada, A. ^{[4
]}

Nomura, K. ^{[5
]}

Fujino, K. ^{[6
]}

Yoshikawa, M. ^{[7
]}

Suzawa, K. ^{[7
]}

Shien, K. ^{[7
]}

Suda, K. ^{[4
]}

Ohara, S. ^{[4
]}

Fukuda, S. ^{[4
]}

Kinoshita, I. ^{[3
]}

Takamori, S. ^{[3
,8
]}

Muto, S. ^{[9
]}

Takanashi, Y. ^{[10
]}

Mizuno, K. ^{[10
]}

Kawase, A. ^{[10
]}

Hayakawa, T. ^{[10
]}

Sekihara, K.

Toda, M. ^{[11
]}

Matsuo, S. ^{[12
]}

Takegahara, K. ^{[13
]}

Hashimoto, M. ^{[13
]}

Nakahashi, K. ^{[14
]}

Endo, M. ^{[14
]}

Ozawa, H. ^{[15
]}

Fujikawa, R. ^{[15
]}

Tomioka, Y. ^{[16
]}

Namba, K. ^{[16
]}

Matsubara, T. ^{[17
]}

Suzuki, J. ^{[18
]}

Watanabe, H. ^{[18
]}

Takada, K. ^{[19
]}

Hoshino, H. ^{[20
]}

Toyoda, T. ^{[21
]}

Koki, Y. ^{[22
]}

Shiono, S. ^{[18
]}

Shimokawa, M. ^{[22
]}

Soh, J. ^{[23
]}

Ohde, Y. ^{[1
]}

Okada, Y. ^{[2
]}

机构：

[1] Shizuoka Canc Ctr, Shizuoka, Japan

[2] Tohoku Univ Hosp, Sendai, Miyagi, Japan

[3] Kyushu Univ, Fukuoka, Japan

[4] Kindai Univ, Fac Med, Osaka, Japan

[5] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[6] Kumamoto Univ, Kumamoto, Japan

[7] Okayama Univ Hosp, Okayama, Japan

[8] Oita Univ, Fac Med, Oita, Japan

[9] Fukushima Med Univ, Sch Med, Fukushima, Japan

[10] Hamamatsu Univ, Sch Med, Shizuoka, Japan

[11] Kansai Rosai Hosp, Amagasaki, Hyogo, Japan

[12] Nihonkai Gen Hosp, Sakata, Yamagata, Japan

[13] Hyogo Coll Med, Nishinomiya, Hyogo, Japan

[14] Yamagata Prefectural Cent Hosp, Yamagata, Japan

[15] Shimada Gen Med Ctr, Shizuoka, Japan

[16] Shimane Univ, Matsue, Shimane, Japan

[17] Kitakyushu Municipal Med Ctr, Fukuoka, Japan

[18] Yamagata Univ, Yamagata, Japan

[19] Saiseikai Fukuoka Gen Hosp, Fukuoka, Japan

[20] NHO Okinawa Hosp, Okinawa, Japan

[21] Chiba Univ, Grad Sch Med, Chiba, Japan

[22] Yamaguchi Univ, Yamaguchi, Japan

[23] Osaka Metropolitan Univ, Grad Sch Med, Osaka, Japan

来源：

JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期

关键词：

uncommon EGFR mutation; surgery; prognosis;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2.07A.03

引用

页码：S232 / S233

页数：2

共 50 条

[21] A case of different EGFR mutations in surgically resected synchronous triple lung cancer
Haratake, Naoki
Takenoyama, Mitsuhiro
Edagawa, Makoto
Shimamatsu, Shinichiro
Toyozawa, Ryo
Nosaki, Kaname
Hirai, Fumihiko
Yamaguchi, Masafumi
Taguchi, Kenichi
Seto, Takashi
Ichinose, Yukito
JOURNAL OF THORACIC DISEASE, 2018, 10 (04) : E255 - E259
[22] Prognostic analysis of patients with mutant and wild-type EGFR gene lung adenocarcinoma
Zheng, Hongmei
Zhang, Yuting
Zhan, Yuting
Liu, Sile
Lu, Junmi
Feng, Juan
Wu, Xia
Wen, Qiuyuan
Fan, Songqing
CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 6139 - 6150
[23] Clinicopathological and prognostic implications of ALK rearrangement in patients with completely surgically resected lung adenocarcinoma
Zhang, Huan
Shan, Guangyao
Cai, Benjie
Bi, Guoshu
Chen, Zhencong
Liang, Jiaqi
Besskaya, Valeria
Zheng, Yuansheng
Guo, Weigang
Wang, Lin
Xu, Songtao
Zhan, Cheng
THORACIC CANCER, 2021, 12 (22) : 3011 - 3018
[24] Prognostic significance of anaplastic lymphoma kinase rearrangement in patients with completely resected lung adenocarcinoma
Liu, Yinglei
Ye, Xiangyun
Yu, Yongfeng
Lu, Shun
JOURNAL OF THORACIC DISEASE, 2019, 11 (10) : 4258 - +
[25] Additional prognostic role of EGFR activating mutations in lung adenocarcinoma patients with brain metastasis: Integrating with lung specific GPA score
Lee, Dae-Won
Shin, Dong-Yeop
Kim, Jin Wook
Keam, Bhumsuk
Kim, Tae Min
Kim, Hak Jae
Kim, Dong-Wan
Wu, Hong-Gyun
Paek, Sun Ha
Kim, Young Whan
Heo, Dae Seog
Kim, Dong Gyu
Lee, Se-Hoon
LUNG CANCER, 2014, 86 (03) : 363 - 368
[26] Different prognostic role of EGFR mutation according to the IASLC histological grade in patients with resected early-stage lung adenocarcinoma
Hong, Tae H.
Hwang, Soohyun
Choi, Yoon-La
Lee, Genehee
Park, Sehhoon
Ahn, Myung-Ju
Lee, Yoonseo
Jeon, Yeong J.
Lee, Junghee
Shin, Sumin
Park, Seong Y.
Cho, Jong H.
Choi, Yong S.
Kim, Jhingook
Shim, Young M.
Cho, Juhee
Kim, Hong K.
HISTOPATHOLOGY, 2023, 83 (02) : 168 - 177
[27] Clinical analysis of Gefitinib in the treatment of stage IV lung adenocarcinoma with unknown EGFR gene mutations
Li, Rong
Lou, Yuqing
Zhang, Yanwei
Shi, Chunlei
Xiong, Liwen
Gu, Aiqin
Han, Baohui
THORACIC CANCER, 2013, 4 (04) : 433 - 439
[28] Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: Are They Different from Those with Common EGFR Mutations?
Jung, Hyun Ae
Park, Sehhoon
Sun, Jong-Mu
Lee, Se-Hoon
Ahn, Jin Seok
Ahn, Myung-Ju
Park, Keunchil
BIOLOGY-BASEL, 2020, 9 (10): : 1 - 10
[29] Bilateral diffuse metastases in advanced lung adenocarcinoma harboring EGFR mutations was associated with a favorable prognosis to EGFR-TKIs
Gu, Zhenbang
Huang, Peng
Zhao, Jiali
Luo, Chen
Liao, Lingmin
Liu, Anwen
Huang, Long
INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (11) : 1979 - 1986
[30] Analyzing EGFR mutations and their association with clinicopathological characteristics and prognosis of patients with lung adenocarcinoma
Zhou, Xiuzhi
Cai, Li
Liu, Junjie
Hua, Xiaomin
Zhang, Ying
Zhao, Huilin
Wang, Bin
Li, Boqing
Gai, Pengzhou
ONCOLOGY LETTERS, 2018, 16 (01) : 362 - 370

← 1 2 3 4 5 →